An estimated 60% of patients with Alzheimer's disease develop epilepsy or subclinical epileptiform activity over the course of the disease. New-onset seizures in cognitively healthy adults also ...

Alzheimer’s disease (AD) is a progressive, neurodegenerative disease characterized by accumulation of beta-amyloid in extracellular plaques and tau protein in intracellular neurofibrillary tangles ...

SALT LAKE CITY — Researchers are slowly tossing much of what we've been told for many years about Alzheimer's disease out the window — and replacing what has been a very dreary tale with new findings ...

A team of American scientists claim they have done something miraculous: they “cured” lab mice suffering from Alzheimer’s disease, which has robbed more than seven million Americans, typically 65 ...

Scientists at Northwestern University used a novel compound to arrest early stages of Alzheimer’s disease in mice — setting the stage, if all goes well, for a groundbreaking treatment in which the ...

Karlawish is a professor of medicine, medical ethics, health policy, and neurology at the University of Pennsylvania’s Perelman School of Medicine, co-director of the Penn Memory Center, and executive ...

A new study presents robust evidence on the role of lysophosphatidylcholines (LPCs) in the onset of Alzheimer’s disease. Researchers discovered that LPCs—compounds that transport a variety of healthy ...

A new study presents robust evidence on the role of lysophosphatidylcholines (LPCs) in the onset of Alzheimer's disease. Researchers discovered that LPCs-compounds that transport a variety of healthy ...

November is Alzheimer’s Awareness Month, a time to heighten awareness about Alzheimer’s disease and show support for the many people and families living with it. First discovered in a 50-year-old ...

News about Alzheimer's rose to the forefront in 2025, as the FDA approved the first diagnostic blood test and drugmakers reported 3-year outcomes for both anti-amyloid drugs, lecanemab (Leqembi) and ...

More than a century ago, Alois Alzheimer noted unusual changes in brain fats, which he described as "lipoid granules," along with the buildup of amyloid‐beta (amyloid) plaques and tau protein tangles.

More than a century ago, Alois Alzheimer noted unusual changes in brain fats, which he described as "lipoid granules," along with the buildup of amyloid-beta (amyloid) plaques and tau protein tangles.